Jump to content
RemedySpot.com

Report on Access to Antiretroviral Drugs by Panos (India)

Rate this topic


Guest guest

Recommended Posts

Guest guest

Antiretroviral drugs for all? Obstacles in accessing treatment

Lessons from India

Access to Antiretrovirals (ARVs) has become the subject of a major debate in

India. As a result of campaigns by civil society activists and groups of

Positive People, as well as commitments at national and international levels,

today more people in India have access to ARVs than two years ago. Yet a great

majority, particularly the most marginalised, still cannot obtain these drugs.

This report, part of a world-wide study conducted by the Panos Global AIDS

Programme, contains a collection of articles from 14 states and union

territories in India on issues around access to antiretrovirals. These articles

are a mix of insiders’ views and journalistic insights. They look at what it

means to get ART from the government programme and outside the government’s

scheme. They identify the obstacles that need to be overcome to ensure

universal access. They contain the voices of Positive People, vulnerable groups,

health professionals, public health experts, government

officials, industry representatives and others involved with the programme.

For more details on the report or to get a copy of the report contact:

Panos India

IInd Floor, D-302, Defence Colony

New Delhi 110024, India

Email: panos@...

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...